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Summary. A simple, selective, and sensitive thin-layer chromatographic–densitometric 
method has been developed for the determination of sulfasalazine besides its possible 
impurities in pharmaceutical preparations. The mobile phase was composed of ethyl  
acetate–methanol–ammonia 25% 10:7:3 (v/v/v), and the stationary phase was aluminum 
plates precoated with silica gel 60 F254 that enabled to obtain well resolved peaks of sul-
fasalazine and its impurities. The developed chromatograms were analyzed densitomet-
rically at λ = 360 nm. RF values and ultraviolet (UV) spectra were used to identify the 
compounds. The developed method is highly sensitive (limit of detection [LOD] = 17.11 
ng spot−1, limit of quantitation [LOQ] = 51.84 ng spot−1), precise (relative standard devia-
tion [RSD] = 1.43%–4.28%), and accurate (RSD = 1.64%–4.27%). The linearity of the 
method was checked within the range 20–120 ng spot−1. The method was successfully 
applied for the determination of sulfasalazine in pharmaceutical preparations besides its 
impurities. The structures of impurities present in the standard substance and in phar-
maceutical preparations were established by ultra-performance liquid chromatography–
tandem mass spectrometry (UPLC–MS/MS) technique. 
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Introduction 
 
Sulfasalazine 5-[4-(2-pyridylsulfamoyl)phenylazo]salicylic acid was de-
signed by Svartz in 1942 by combining an antibiotic sulfapyridine with an 
anti-inflammatory agent 5-aminosalicylic acid through an azo bond [1]. Sul-
fasalazine is a bright-yellow or brownish-yellow fine powder, practically in-
soluble in water, very slightly soluble in alcohol, practically insoluble in me-
thylene chloride, but well soluble in dilute solutions of alkali hydroxides [2]. 
Sulfasalazine is commonly used in the treatment of inflammatory bowel 
diseases such as rheumatoid arthritis, Crohn's disease and ulcerative colitis 
[3]. Sulfasalazine can reverse the scarring associated with cirrhosis of the 
liver. Myofibroblasts cells contribute to scar tissue in a diseased liver; these 
cells also secrete proteins that prevent the breakdown of the scar tissue. Sul-
fasalazine retards this secretion. It also helps in healing cirrhosis of the liver 
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[4]. However, it can cause adverse effects which may lead to disorder of the 
hemopoietic system and potential carcinogenic effects. Different analytical 
methods were applied for the determination of sulfasalazine in pharmaceu-
tical preparations and biological fluids. For the assessment of sulfasalazine 
in several biological matrices, an enzyme-linked immunosorbent assay 
method based on polyclonal antibodies was developed and characterized 
[1]. Ultraviolet (UV) spectrophotometric method was applied for the quanti-
tative determination of sulfasalazine in tablet dosage form [5]. Two kinetic 
spectrophotometric methods were developed for the determination of sul-
fasalazine in pure form and in pharmaceutical formulations. The first meth-
od was based upon the kinetic investigation of the oxidation reaction of sul-
fasalazine with alkaline potassium permanganate at room temperature for 
fixed time yielding a green color of manganate ion. The second method was 
based upon the oxidation reaction of sulfasalazine with a mixture of iodine 
and potassium iodide at room temperature [6]. Sulfasalazine and its main 
metabolites sulphapyridine and 5-aminosalicylic acid were determined in 
human plasma by liquid chromatography–mass spectrometry (LC–MS) 
method using XBP Phenyl column [7]. Sulfasalazine was also determined in 
pharmaceutical and biological samples using molecularly imprinted poly-
mer modified carbon paste electrode. Trace amount of sulfasalazine was de-
termined by using differential pulse voltammetry method based on electro-
chemical reduction of sulfasalazine at the modified electrodes [8]. An ana-
lytical method based on capillary electrophoresis and tandem mass spec-
trometry was proposed and validated for the identification and simultane-
ous quantification of 12 sulfonamides including sulfasalazine in pork meat 
[9].  
The aim of this study was to develop a chromatographic–densitometric 
method for the determination of sulfasalazine besides its possible impurities 
in pharmaceutical preparations. It has been shown that this technique has 
many advantages, such as providing an accurate, quick, and simple deter-
mination and can be an alternative to the commonly used LC methods. The 
determined impurities were also subjected to ultra-performance liquid 
chromatography–tandem mass spectrometry (UPLC–MS/MS) analysis to 
establish their chemical structures.  
Experimental 
Chemicals and Preparations 
• Standard substance: sulfasalazine — 5-[4-(2-pyridylsulfamoyl)- 
phenylazo]salicylic acid (Sigma-Aldrich GmbH, St. Louis, MO, 
USA) 
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• Chemical reagents: ethyl acetate (POCh), methanol (Merck), ammo-
nia 25% (POCh), water (Merck), acetonitrile (Merck), formic acid 
(Merck), and sodium hydroxide (POCh). All reagents were of ana-
lytical grade 
• Pharmaceutical preparations: Sulfasalazin EN 500 mg (Krka, Novo 
mesto, Slovenia) and Salazopyrin EN 500 mg (Pfizer Health AB, 
Stockholm, Sweden) 
 
Solutions for Analysis 
 
Standard solutions were prepared by dissolving an appropriate amount of 
standard substance of sulfasalazine in 0.1 mol L−1 NaOH to give a concen-
tration of 0.1% (w/v). Then, the solution was diluted with the same solvent 
to obtain a concentration of 0.001% (w/v) for linearity and precision studies. 
Standard solution of sulfasalazine at a concentration of 0.1% (w/v) was used 
for the purity studies. 
Preparation solutions were prepared by grinding ten tablets of a phar-
maceutical preparation in a mortar, weighing with a precision of 0.1 mg the 
amount of tablet powder corresponding to 25 mg of sulfasalazine and shak-
ing for 30 min with 15 mL of 0.1 mol L−1 NaOH in a 25-mL volumetric flask. 
Then the flask was filled with 0.1 mol L−1 NaOH to the specified volume 
and placed in an ultrasonic bath for 30 min. After that, the solution was fil-
tered and diluted with 0.1 mol L−1 NaOH to obtain a concentration of 
0.001% (w/v).  
 
Chromatography 
 
Standard solution of sulfasalazine was applied in 8 mm bands, 10 mm 
apart, and 10 mm from the lower edge to thin-layer chromatography (TLC) 
silica gel 60 F254 plates (65 × 100 mm) using CAMAG sample applicator Li-
nomat 4 equipped with a 100-μL syringe at a constant application rate of  
200 nL s−1. Chromatograms were developed over a distance of 95 mm using 
ethyl acetate–methanol–ammonia 25% 10:7:3 (v/v/v) in a chromatographic 
chamber 18 × 9 × 18 cm in size (Sigma-Aldrich, USA) saturated for 10 min 
with the mobile phase vapour at room temperature. The mobile phase was 
chosen experimentally after checking 20 different mobile phases. After de-
velopment, the TLC plates were dried at room temperature and scanned at 
360 nm, which was chosen on the basis of an absorption spectrum recorded 
directly from the chromatogram. The analytical wavelength was the same 
for sulfasalazine and its impurities. Densitometric scanning was carried out 
using a TLC Scanner 3 (CAMAG, Switzerland) controlled by win CATS 
1.3.4 software resident in the system in the linear absorbance-reflectance 
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mode. The slit dimensions were 8 × 0.6 mm, the scanning speed was 20 
mm s−1, and data resolution was 100 μm step−1. Retardation factors (RF val-
ues) were used to identify sulfasalazine and its possible impurities. Good 
separation and well-developed peaks were obtained in a short time (ap-
proximately 30 min). 
 
Validation of the Method 
 
The optimized method was validated for the determination of sulfasalazine 
in the presence of its impurities according to the International Conference 
on Harmonization (ICH) guidelines [10, 11]. 
 
 
Specificity 
 
The specificity of the method was ascertained by comparing chroma-
tograms of sulfasalazine obtained for standard solution, preparation 
solution, and blank chromatogram. In the obtained chromatograms, the 
retardation factor (RF) values of analyzed substances, resolution factor, and 
peak areas were taken into account. Resolution factor (Rs) was calculated 
using the formula: 
Rs = 2 × (distance between the centers of two adjacent spots)/(sum of 
the two spots in the direction of development). 
 
 
Linearity 
 
 To check linearity of the method, 2, 4, 6, 8, 10, and 12 μL of sulfasalazine 
standard solution at a concentration of 0.001% w/v were applied to the 
chromatographic plate 120 × 100 mm in size. Linearity was determined 
based on the relationship between the peak areas and sulfasalazine mass 
(ng spot−1). The regression plot, regression equation, coefficient of 
determination r2, and the distribution of residuals by Shapiro–Wilk 
normality test were calculated by Statistica 10.0 and are indicative of 
linearity.  
 
Precision 
 
The intra-day and inter-day precisions of the method were derived from the 
degree of consistency of the recorded peak areas for sulfasalazine standard 
solution. Six determinations were made by applying 60 ng spot−1 at 100% 
level, 30 ng spot−1 at 50% level, and 90 ng spot−1 at 150% level to the plate 
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followed by the analysis according to the method conditions. The inter-day 
precision was carried out after 1 week by a different analyst. The precision 
was estimated using peak areas and was evaluated as the standard 
deviation (SD) and relative standard deviation (RSD) values.  
 
 
LOD and LOQ 
 
To determine the limit of detection (LOD) and limit of quantitation (LOQ), 
standard error of the estimate, the slope of the linear calibration plot, and 
the following equations were used: LOD = 3.3 × Se/a and LOQ = 10 × Se/a, 
where Se = standard error of the estimate and a = slope of a straight line. 
 
 
Accuracy 
 
The accuracy of the method was determined by spiking the standard solu-
tion of sulfasalazine into sample solution in the amounts of 80–120% of the 
level in the preparations under examination. The obtained results were 
compared with the expected results and the recovery of the added drug was 
expressed as a percentage. 
 
Robustness 
 
To examine robustness, the most significant chromatographic parameters 
were changed within the range of 1–5% compared to those of the optimal 
conditions, while keeping the other parameters unchanged. The following 
parameters were examined: proportions of methanol and ammonia in the 
mobile phase, the mobile phase volume, the developing distance, saturation 
time of the chromatographic chamber. The influence of the stationary phase 
was also checked by application to HPTLC plates instead of TLC plates.  
As a result of the determinations carried out, analysis conditions, 
which were later used to determine the sulfasalazine content in pharma-
ceutical preparations and to check its purity, were established. 
 
 
Identification of Possible Impurities by UPLC–MS/MS 
 
The UPLC–MS/MS system consisted of a Waters ACQUITY® UPLC® (Wa-
ters Corporation, Milford, MA, USA) coupled to a Waters TQD mass spec-
trometer (electrospray ionization mode electrospray ionization (ESI)–
tandem quadrupole). Chromatographic separations were carried out using 
the Acquity UPLC BEH (bridged ethyl hybrid) C18 column: 2.1 × 100 mm 
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and 1.7 μm particle size. The column was maintained at 40 °C and eluted 
under gradient conditions from 95% to 0% of eluent A over 10 min, at a flow 
rate of 0.3 mL min−1 (eluent A: formic acid–water [0.1%, v/v]; eluent B: for-
mic acid–acetonitrile [0.1%, v/v]). One microliter of each sample was in-
jected. 
Chromatograms were made using Waters eλ PDA detector. Spectra 
were analyzed in 200–700 nm range with 1.2 nm resolution and sampling 
rate of 20 points/s. 
MS detection settings of Waters TQD mass spectrometer were as fol-
lows: source temperature, 150 °C; desolvation temperature, 350 °C; desolva-
tion gas flow rate, 600 L h−1; cone gas flow, 100 L h−1; capillary potential, 
3.00 kV; and cone potential, 20 V. Nitrogen was used as both nebulizing and 
drying gas. The data were obtained in a scan mode ranging from 50 to 1000 
m/z at 0.5 s time intervals.  
 
 
Determination of Sulfasalazine and Its Impurities in 
Pharmaceutical Preparations 
 
In order to determine the sulfasalazine content, bands of solutions (6 μL of 
standard solution and preparation solution) were applied to the 120 ×  
100 mm chromatographic plates of silica gel 60 F254 (cut from 20 × 20 cm be-
fore use). The purity of the drugs was determined by using 20 μL of the 
preparation solutions at a concentration of 1 mg mL−1. Chromatograms 
were developed to a distance of 95 mm with the experimentally chosen mo-
bile phase and then dried at room temperature. Densitometric scanning was 
performed at 360 nm, and peak areas were recorded. The concentration of 
sulfasalazine in preparations under examination was computed by compar-
ing the peak areas for the standard and sample solutions. For quantitative 
determination of sulfasalazine impurities, the scan areas of appropriate 
peaks were recorded and the relative percent concentrations computed by 
employing the internal normalization method, according to the formula:  
i [%] = (xi/Σx) 100, where i [%] is constituent concentration, xi is peak area 
for the determined constituent, and Σx is sum of peak scan areas in the 
chromatogram.  
 
Results and Discussion 
 
The aim of this paper was to establish a simple and accurate method for 
quantitative determination of sulfasalazine and its possible impurities in 
pharmaceutical preparations by a TLC–densitometric method.  
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(A) 
 
 
(B) 
Fig. 1. Absorption spectra of sulfasalazine (A) and its impurities (B–1, 2, and 3) registered 
directly from the chromatogram 
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By using TLC silica gel 60 F254 plates as a stationary phase and ethyl ac-
etate–methanol–ammonia 25% 10:7:3 (v/v/v) as the mobile phase, good 
separation of constituents under investigation was obtained. The eluent 
mixture was chosen experimentally after checking about 20 different mobile 
phases. Chromatograms were developed for ∼30 min. The retardation factor 
for sulfasalazine was RF = 0.75 and for impurities was as follows: 0.56 for 
impurity 1, 0.61 for impurity 2, and 0.88 for impurity 3. 
Registration of peak areas for sulfasalazine and its impurities was car-
ried out in UV at λ = 360 so that the simultaneous determination of sulfasa-
lazine beside possible impurities was possible (Fig. 1). 
Table I. Summary of the validation results for the determination of sulfasalazine 
Parameter Result 
RF 0.75 
Linearity 
Linearity range (ng spot−1): 
20–120 
P = ac + b 
a = 35.218; b = 391.08 
Sa = 2.18; Sb = 169.96 
r = 0.9924 
Shapiro–Wilk normality test:  
W = 0.94204; p = 0.67568 
LOD (ng spot−1) 17.11 
LOQ (ng spot−1) 51.84 
Accuracy (%) 
n = 5 
Level 80%: xmean = 98.31 
S = 4.20 
RSD = 4.27% 
Level 100%: xmean = 101.43 
S = 1.66 
RSD = 1.64% 
Level 120%: xmean = 100.95 
S = 2.95 
RSD = 2.92% 
Intra-day precision 
n = 5 
Level 50%: xmean = 1383.68 
S = 40.8261 
RSD = 2.95% 
Level 100%: xmean = 2771.62 
S = 118.6253 
RSD = 4.28% 
Level 150%: xmean = 3579.68 
S = 51.0468 
RSD = 1.43% 
Inter-day precision 
n = 5 
xśr = 2241.32 
S = 44.94 
RSD = 2.01% 
P—peak area; c—concentration; r—correlation coefficient; S—standard deviation; 
RSD—relative standard deviation (%); Sa—standard deviation of slope; Sb—standard de-
viation of intercept. 
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Linearity
P     = 391,08 + 35,218 * c
 r =   ,99241
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Fig. 2. Calibration plot (A) and plot of residuals (B) for sulfasalazine in the 
 linear working range 
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For quantitative analysis of sulfasalazine, peak areas for standard solu-
tion, and examined solutions were used. Validation of the developed meth-
od proved that it meets the acceptance criteria in the scope of specificity, 
sensitivity, linearity, precision, and accuracy (Table I). 
The developed method is specific against sulfasalazine in a concentra-
tion range. For sample solutions used for quantitative analysis, no spots 
were found other than those of sulfasalazine. The measurement spots 
showed overlaying spectra, which indicates that there are no interferences. 
The calibration curve for sulfasalazine was obtained by plotting the 
peak area versus concentration. It was found to be linear in the range 20–
120 ng spot−1 (Fig. 2). The correlation coefficient (r) was found to be r = 0.99 
showing good linearity. The adequacy of the regression model was exam-
ined by plotting the residuals. The obtained plots of residuals were without 
trends, which proves the linearity of the working range.  
The developed method is sufficiently sensitive. The LOD and LOQ  
are both sufficiently low for the determination of low concentrations  
17.11 ng spot−1 and 51.84 ng spot−1, respectively).  
Precision studies were carried out at three different concentration lev-
els, and the results of the intra-day and inter-day studies are presented in 
RSD within the range 1.43–4.28%.  
The recovery of the added standard to the sample was calculated, and 
it was found to be about 100%, which indicated good accuracy of the meth-
od.  
Under the developed method conditions, the small changes of analyti-
cal parameters do not have any significant influence on determined results.  
Resolution and separation factors calculated for sulfasalazine and its 
impurities are satisfactory (Table II). 
 
Table II. Resolution and separation factor for sulfasalazine and its impurities 
Examined peaks Resolution (Rs) Separation factor (α) 
Sulfasalazine + imp 1 1.37 2.32 
Sulfasalazine+ imp 2 1.19 1.90 
Sulfasalazine + imp 3 1.02 2.37 
 
 
Absorption spectra registered for the impurities and sulfasalazine 
standard substance are similar with absorption maximum at 360 nm. Ex-
traction of impurities from the chromatographic silica gel and analysis of 
the extract by UPLC–MS/MS enabled to establish the chemical structures of 
the determined impurities that are presented in Table III. 
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Table III. Impurities of sulfasalazine standard substance identified by UPLC–MS/MS 
RF [M + H+] Proposed structure Name 
0.56 250.12 
NH2
S
NH
O O
N
 
4-Amino-N-(pyridin-2-
yl)benzenesulfonamide  
0.61 335.21 
OH
HO2C
N
N
N
NH
2-Hydroxy-5-((4-(2-iminopyridin-
1(2H)-yl)phenyl)diazenyl)benzoic ac-
id 
0.75 399.16 
OH
HO2C
N
N
S
NH
O O
N
 
2-Hydroxy-5-((4-(N-(pyridin-2-
yl)sulfamoyl)phenyl)diazenyl)benzoic 
acid  
(sulfasalazine) 
0.88 355.15 
N
S
NH
O O
N
N
OH  
4-((2-Hydroxyphenyl)diazenyl)-N-
(pyridin-2-yl)benzenesulfonamide 
 
 
The proposed chromatographic procedure was applied for the quanti-
tative determination of sulfasalazine in pharmaceutical preparations. The 
determined content of sulfasalazine in commercial pharmaceutical prepara-
tions matched with the label claim (RSD values 2.20%–3.39%). The obtained 
results with the statistical estimation are presented in Table IV.  
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Table IV. Determination of sulfasalazine and its impurities in pharmaceutical 
preparations 
Concentration of impurities (n = 5) Pharmaceutical 
preparation 
Determined 
content (n = 5) Imp 1 Imp 2 Imp 3 
Sulfasalazin  
EN 500 mg 
xmean = 97.88% 
S = 3.3214 
RSD = 3.39% 
xmean = 2.62%
S = 0.0771 
RSD = 2.94% 
xmean = 7.27%
S = 0.1286 
RSD = 1.77% 
xmean = 1.38% 
S = 0.0661 
RSD = 4.79% 
Salazopyrin  
EN 500 mg 
xmean = 100.28%
S = 2.2118 
RSD = 2.20% 
xmean = 2.67%
S = 0.0743 
RSD = 2.78% 
xmean = 6.71%
S = 0.1016 
RSD = 1.51% 
xmean = 1.74% 
S = 0.0611 
RSD = 3.51% 
 
In further analysis, the purity of the analyzed drugs by the presented 
method has been evaluated. Preparation solutions at a concentration of  
1.0 mg mL−1 of sulfasalazine were analyzed by the TLC–densitometric 
method as described above. On the registered densitograms, additional 
peaks beside the peak of active substance of RF values 0.56 for impurity 1, 
0.61 for impurity 2, and 0.88 for impurity 3 were observed (Fig. 3). The con-
centration of impurities was determined by the internal normalization 
method. Determined concentration of impurities is similar in both prepara-
tions. The obtained results are presented in Table IV. 
 
 
Fig. 3. Example densitogram for the purity determination of Sulfasalazin EN preparation 
registered at 360 nm. Peaks 1, 2, and 4—impurities; peak 3—sulfasalazine 
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Conclusion 
 
This study indicates that the developed chromatographic–densitometric 
method presented in this paper is suitable for the determination of sulfasa-
lazine in pharmaceutical preparations and for purity assessment of active 
substance beside possible impurities in pharmaceutical preparations. The 
developed method may be used as an alternative to pharmacopoeial meth-
ods. 
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